These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
563 related items for PubMed ID: 19369901
1. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. de Sá BC, Fugimori ML, Ribeiro Kde C, Duprat Neto JP, Neves RI, Landman G. Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901 [Abstract] [Full Text] [Related]
2. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA. Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944 [Abstract] [Full Text] [Related]
3. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas. Richmond-Sinclair NM, Lee E, Cummings MC, Williamson R, Muller K, Green AC, Hayward NK, Whiteman DC. Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132 [Abstract] [Full Text] [Related]
4. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions. Demirkan NC, Kesen Z, Akdag B, Larue L, Delmas V. Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395 [Abstract] [Full Text] [Related]
5. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL. Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741 [Abstract] [Full Text] [Related]
6. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP. J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102 [Abstract] [Full Text] [Related]
7. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas. Stefanaki C, Stefanaki K, Antoniou C, Argyrakos T, Stratigos A, Patereli A, Katsambas A. J Cutan Pathol; 2008 Sep 15; 35(9):799-808. PubMed ID: 18494826 [Abstract] [Full Text] [Related]
8. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA. Clin Cancer Res; 2003 Aug 15; 9(9):3383-8. PubMed ID: 12960126 [Abstract] [Full Text] [Related]
9. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T. Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846 [Abstract] [Full Text] [Related]
10. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters. Poyraz A, Akyürek N, Gönül II, Erdem O. J Exp Clin Cancer Res; 2004 Dec 15; 23(4):625-31. PubMed ID: 15743033 [Abstract] [Full Text] [Related]
11. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Sanki A, Li W, Colman M, Karim RZ, Thompson JF, Scolyer RA. Pathology; 2007 Dec 15; 39(6):551-7. PubMed ID: 18027257 [Abstract] [Full Text] [Related]
12. Cyclin D1 expression in melanocytic lesions of the skin. Ramirez JA, Guitart J, Rao MS, Diaz LK. Ann Diagn Pathol; 2005 Aug 15; 9(4):185-8. PubMed ID: 16084449 [Abstract] [Full Text] [Related]
13. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations]. Liu JH, Huang H, Huang X, Zeng MS, Li W. Zhonghua Yi Xue Za Zhi; 2006 Feb 07; 86(5):312-6. PubMed ID: 16677523 [Abstract] [Full Text] [Related]
14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E. Int J Clin Pract; 2008 Nov 07; 62(11):1736-43. PubMed ID: 19143860 [Abstract] [Full Text] [Related]
15. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Flørenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R. Clin Cancer Res; 2000 Sep 07; 6(9):3614-20. PubMed ID: 10999753 [Abstract] [Full Text] [Related]
16. PUMA expression is significantly reduced in human cutaneous melanomas. Karst AM, Dai DL, Martinka M, Li G. Oncogene; 2005 Feb 03; 24(6):1111-6. PubMed ID: 15690057 [Abstract] [Full Text] [Related]
17. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Kim LH, Peh SC, Poppema S. Hum Pathol; 2006 Jan 03; 37(1):92-100. PubMed ID: 16360421 [Abstract] [Full Text] [Related]
18. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Straume O, Sviland L, Akslen LA. Clin Cancer Res; 2000 May 03; 6(5):1845-53. PubMed ID: 10815907 [Abstract] [Full Text] [Related]
19. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. Bachmann IM, Straume O, Akslen LA. Int J Oncol; 2004 Dec 03; 25(6):1559-65. PubMed ID: 15547691 [Abstract] [Full Text] [Related]
20. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R. J Pathol; 2001 Dec 03; 195(5):530-6. PubMed ID: 11745687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]